Abstract:Background
Each year, approximately 30,000 people have an out-of-hospital cardiac arrest (OHCA) that is treated by UK ambulance services. Across all cases of OHCA, survival to hospital discharge is less than 10%. Acute coronary syndrome (ACS) is a common cause of OHCA.
Objectives
To explore factors that influence survival in patients who initially survive an OHCA attributable to ACS.
… Show more
“…Because of the limitations of ICD‐10 coding, we were unable to accurately differentiate shockable (VT or VF) versus nonshockable (bradyarrhythmia or pulseless electrical activity) rhythms during CA. However, previous data from a similar cohort suggested that 89.6% of patients who have out‐of‐hospital CA in the context of ACS have VT or VF as the presenting rhythm, 1 which provide the basis for our assumption that the vast majority of CAs at the time of ACS in our study are attributed to VAs.…”
Section: Discussionmentioning
confidence: 58%
“…A minority of acute coronary syndrome (ACS) patients who survive to hospital admission are associated with ventricular arrhythmia (VA), a subset of which cause cardiac arrest (CA). 1 Acute myocardial ischemia leads to a series of progressive electrophysiological changes at the cellular level that predispose to VA, 2 although it remains unclear why only a minority of patients with ACS develop VA, whereas the vast majority do not. 3 …”
Background
A minority of acute coronary syndrome (ACS) cases are associated with ventricular arrhythmias (VA) and/or cardiac arrest (CA). We investigated the effect of VA/CA at the time of ACS on long‐term outcomes.
Methods and Results
We analyzed routine clinical data from 5 National Health Service trusts in the United Kingdom, collected between 2010 and 2017 by the National Institute for Health Research Health Informatics Collaborative. A total of 13 444 patients with ACS, 376 (2.8%) of whom had concurrent VA, survived to hospital discharge and were followed up for a median of 3.42 years. Patients with VA or CA at index presentation had significantly increased risks of subsequent VA during follow‐up (VA group: adjusted hazard ratio [HR], 4.15 [95% CI, 2.42–7.09]; CA group: adjusted HR, 2.60 [95% CI, 1.23–5.48]). Patients who suffered a CA in the context of ACS and survived to discharge also had a 36% increase in long‐term mortality (adjusted HR, 1.36 [95% CI, 1.04–1.78]), although the concurrent diagnosis of VA alone during ACS did not affect all‐cause mortality (adjusted HR, 1.03 [95% CI, 0.80–1.33]).
Conclusions
Patients who develop VA or CA during ACS who survive to discharge have increased risks of subsequent VA, whereas those who have CA during ACS also have an increase in long‐term mortality. These individuals may represent a subgroup at greater risk of subsequent arrhythmic events as a result of intrinsically lower thresholds for developing VA.
“…Because of the limitations of ICD‐10 coding, we were unable to accurately differentiate shockable (VT or VF) versus nonshockable (bradyarrhythmia or pulseless electrical activity) rhythms during CA. However, previous data from a similar cohort suggested that 89.6% of patients who have out‐of‐hospital CA in the context of ACS have VT or VF as the presenting rhythm, 1 which provide the basis for our assumption that the vast majority of CAs at the time of ACS in our study are attributed to VAs.…”
Section: Discussionmentioning
confidence: 58%
“…A minority of acute coronary syndrome (ACS) patients who survive to hospital admission are associated with ventricular arrhythmia (VA), a subset of which cause cardiac arrest (CA). 1 Acute myocardial ischemia leads to a series of progressive electrophysiological changes at the cellular level that predispose to VA, 2 although it remains unclear why only a minority of patients with ACS develop VA, whereas the vast majority do not. 3 …”
Background
A minority of acute coronary syndrome (ACS) cases are associated with ventricular arrhythmias (VA) and/or cardiac arrest (CA). We investigated the effect of VA/CA at the time of ACS on long‐term outcomes.
Methods and Results
We analyzed routine clinical data from 5 National Health Service trusts in the United Kingdom, collected between 2010 and 2017 by the National Institute for Health Research Health Informatics Collaborative. A total of 13 444 patients with ACS, 376 (2.8%) of whom had concurrent VA, survived to hospital discharge and were followed up for a median of 3.42 years. Patients with VA or CA at index presentation had significantly increased risks of subsequent VA during follow‐up (VA group: adjusted hazard ratio [HR], 4.15 [95% CI, 2.42–7.09]; CA group: adjusted HR, 2.60 [95% CI, 1.23–5.48]). Patients who suffered a CA in the context of ACS and survived to discharge also had a 36% increase in long‐term mortality (adjusted HR, 1.36 [95% CI, 1.04–1.78]), although the concurrent diagnosis of VA alone during ACS did not affect all‐cause mortality (adjusted HR, 1.03 [95% CI, 0.80–1.33]).
Conclusions
Patients who develop VA or CA during ACS who survive to discharge have increased risks of subsequent VA, whereas those who have CA during ACS also have an increase in long‐term mortality. These individuals may represent a subgroup at greater risk of subsequent arrhythmic events as a result of intrinsically lower thresholds for developing VA.
“…Finally, transfer to a cardiac arrest centre is thought to improve survival following OHCA but a potential effect size has not been clearly defined. 28,29 In our study, bypass of the nearest hospital in favour of a cardiac centre was a relatively common prehospital critical care intervention. However, the receiving hospital for patients in the ALS group was a cardiac arrest centre in nearly half of the patients transferred, thereby diluting a potentially small to moderate effect of prehospital critical care.…”
Section: Explanations Of Research Findingsmentioning
Aim To examine the effect of prehospital critical care on survival following OHCA, compared to routine advanced life support (ALS) care. Methods We undertook a prospective multi-centre cohort study including two ambulance services and six prehospital critical care services in the United Kingdom (UK), between September 2016 and October 2017. Inclusion criteria were adult patients with non-traumatic OHCA treated by either prehospital critical care teams or ALS paramedics. Patients who received prehospital critical care were matched to those receiving ALS using propensity score matching. Primary outcome was survival to hospital discharge; secondary outcome was survival to hospital admission. Results The primary analysis included 658 patients with OHCA receiving prehospital critical care and 1,847 patients receiving ALS care. Rates of survival to hospital discharge (primary outcome) were 11.9% in both groups; rates of survival to hospital admission (secondary outcome) were 34.4% and 27.7% in the prehospital critical care and ALS group, respectively. The corresponding odds ratios for survival to hospital discharge and survival to hospital admission with prehospital critical care were 1.06 (95% confidence interval 0.75-1.49) and 1.39 (95% confidence interval 1.10-1.75), respectively. Results were consistent across subgroups and sensitivity analyses. Conclusions Despite a positive association with the secondary outcome of survival to hospital admission, prehospital critical care was not associated with increased rates of survival to hospital discharge following OHCA.
“…Nevertheless, there is much variability in longterm prognosis for patients with acute coronary syndrome who survive to be discharged from the hospital. 7,8 Some studies have been conducted in Iran to determine the survival rate in different provinces, but none of them has been population-based, considering the whole country using MI registry data and type of drugs prescribed at the time of discharge. Therefore, this retrospective cohort study was designed to estimate short-and long-term survival rates in MI patients and their contributing factors and medications prescribed at the time of discharge in patients with the first attack of MI in the Islamic Republic of Iran.…”
Background: Coronary artery disease is among the first causes of death in Iran. Secondary prevention with drug therapy is recommended following acute myocardial infarction (MI) to reduce the risk of new cardiovascular events and death. Methods: This is a retrospective cohort study on data collected from 21181 cases of MI recorded by the MI Registry of Iran from 2013 to 2014. Ten therapies that were prescribed to patients at the time of discharge were divided into 6 groups. Survival rates were estimated using the Kaplan-Meier method and Cox regression analysis. Results: The most common MI location was in the anterior wall (31.87%). Anticoagulants, aspirin, clopidogrel were the most common prescribed medications (94.73%). Overall, 28-day (short-term) and 3-year survival rates were 0.95 (95% CI: 0.95–0.96) and 0.82 (95% CI: 0.81–0.82). In non-ST-elevation myocardial infarction (NSTEMI) patients, the lowest short- and long-term survival rates were observed when diuretic, anticoagulants/ aspirin and clopidogrel, beta-blockers and statins medication were simultaneously taken and the highest short- and long-term survival rates were observed in patients who took anticoagulants, aspirin and clopidogrel, nitrate agent and calcium blockers, beta-blockers and statins medication. In STEMI patients, the lowest short- and long-term survival rates were observed when diuretic, anticoagulants, aspirin and clopidogrel, nitrate agent and calcium blockers, angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) were simultaneously taken. The highest short- and long-term survival rates were observed in patients who received anticoagulants, aspirin and clopidogrel, nitrate agent and calcium blockers, beta-blockers, statins, ACEIs and ARBs. Conclusion: Prescription of the best combination of drugs, in addition to adherence to a healthy lifestyle and medication, can improve the survival rates after MI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.